The efficacy of Myrtus Communis suppository on hemorrhoids
Not Applicable
Recruiting
- Conditions
- hemorrhoids.Hemorrhoids and perianal venous thrombosis
- Registration Number
- IRCT20130211012438N26
- Lead Sponsor
- Barij Research Center of Medicinal Herbs
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
All the visited patients with Type1 and 2 hemorrhoids who do not need emergency surgery referred to presenter office
Exclusion Criteria
External thrombosed hemorrhoid
Internal strangulated hemorrhoid
Anal fistula
Anal fissure
Anal abscess
Portal hypertension
Type 3 and 4 hemorrhoids
Renal insufficiency
Malignancies
Pregnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding. Timepoint: Before intervention, 2 weeks after the initial intervention. Method of measurement: questionnaire.;Pain during bowel movements. Timepoint: Before intervention, 2 weeks after initiation of intervention. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of Myrtus Communis essential oil contribute to hemorrhoidal inflammation reduction?
How does Myrtus Communis suppository efficacy compare to standard treatments like topical corticosteroids for hemorrhoids?
Are there specific biomarkers predictive of response to Myrtus Communis suppository in patients with perianal venous thrombosis?
What adverse events are associated with Myrtus Communis suppository use in hemorrhoid therapy, and how are they managed?
Are there synergistic effects when combining Myrtus Communis essential oil with flavonoid-based hemorrhoid treatments?